A detailed history of Sweet Financial Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sweet Financial Partners, LLC holds 6,622 shares of ABT stock, worth $779,078. This represents 0.17% of its overall portfolio holdings.

Number of Shares
6,622
Previous 6,936 4.53%
Holding current value
$779,078
Previous $720,000 4.72%
% of portfolio
0.17%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$100.07 - $118.13 $31,421 - $37,092
-314 Reduced 4.53%
6,622 $754,000
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $138,503 - $154,605
-1,375 Reduced 16.54%
6,936 $720,000
Q1 2024

Apr 23, 2024

SELL
$109.52 - $120.96 $1.46 Million - $1.61 Million
-13,331 Reduced 61.6%
8,311 $944,000
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $16,955 - $20,755
-188 Reduced 0.86%
21,642 $2.38 Million
Q3 2023

Oct 23, 2023

BUY
$95.53 - $114.62 $92,473 - $110,952
968 Added 4.64%
21,830 $2.11 Million
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $470,944 - $524,731
4,673 Added 28.87%
20,862 $2.27 Million
Q1 2023

Apr 14, 2023

BUY
$96.86 - $114.01 $327,289 - $385,239
3,379 Added 26.38%
16,189 $1.64 Million
Q4 2022

Jan 19, 2023

BUY
$95.06 - $111.52 $303,146 - $355,637
3,189 Added 33.15%
12,810 $0
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $63,764 - $73,827
659 Added 7.35%
9,621 $931,000
Q2 2022

Aug 03, 2022

BUY
$102.07 - $123.37 $156,371 - $189,002
1,532 Added 20.62%
8,962 $974,000
Q1 2022

Apr 22, 2022

BUY
$114.02 - $139.04 $353,462 - $431,024
3,100 Added 71.59%
7,430 $879,000
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $500,244 - $612,521
4,330 New
4,330 $609,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sweet Financial Partners, LLC Portfolio

Follow Sweet Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sweet Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sweet Financial Partners, LLC with notifications on news.